What is it about?
Cancer patients have an increased risk of suffer from active tuberculosis. We decided to evaluate two test to diagnose latent tuberculosis infection (QuantiFERON®-TB and tuberculin skin test) in 149 patients. A 21.5% of patients had a positive results on either test. Tests agreement was moderate but it improved marginally when the cut-off points that define what is positive or not on either test were changed.
Featured Image
Photo by National Cancer Institute on Unsplash
Why is it important?
Cancer patients is a population at risk of tuberculosis. Our findings suggest that modifying cut-off points may improve agreement of tests.
Perspectives
I hope this article remarks the importance of tuberculosis in populations at risk. This article may lead to evaluate the cut-off points of tests evaluated to improve their performance.
Dr. Javier Leonardo Galindo Pedraza
Hospital Universitario Mayor
Read the Original
This page is a summary of: Comparison of the QuantiFERON-TB and tuberculin skin test for detection of latent tuberculosis infection in cancer patients in a developing country, ERJ Open Research, October 2019, European Respiratory Society (ERS),
DOI: 10.1183/23120541.00258-2018.
You can read the full text:
Contributors
The following have contributed to this page